Integration of active tuberculosis case finding in a mobile HIV-testing clinic is feasible

A research article by Katharina Kranzer from the London School of Hygiene & Tropical Medicine and colleagues describe the feasibility and costs of an active tuberculosis case finding project in Cape Town, South Africa. The study describes the integration of tuberculosis testing into a mobile HIV testing service for HIV-negative individuals with symptoms suggestive of tuberculosis and all HIV-positive individuals. The mobile testing clinic, named the Tutu Tester after Archbishop Emeritus Desmond Tutu, visits underserviced areas in greater Cape Town and provides testing services for deprived communities. The study demonstrates that active tuberculosis case finding in settings with a high burden of HIV and tuberculosis is feasible and has a high uptake, yield, and treatment success. However, the authors note that further work is required to determine whether mobile active tuberculosis case finding is cost-effective and whether the service can be scaled up.

INFORMATION:

Funding: The study was funded by the Wellcome Trust. KK and SDL had support from the Wellcome Trust, RW had support from IEDEA (5U01AI069924-02, CEPAC (5 R01 AI058736-02), USAID Right to Care (CA 674 A 00 08 0000 700), CIPRA (IU19AI53217-07), LGB had support from NIH CIPRA (1U19AI053217). The mobile clinic used in this study was funded by the following sources: USAID and Agence Francaise de Developpment. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: The authors have declared that no competing interests exist.

Citation: Kranzer K, Lawn SD, Meyer-Rath G, Vassall A, Raditlhalo E, et al. (2012) Feasibility, Yield, and Cost of Active Tuberculosis Case Finding Linked to a Mobile HIV Service in Cape Town, South Africa: A Cross-sectional Study. PLoS Med 9(8): e1001281. doi:10.1371/journal.pmed.1001281

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER (THIS LINK WILL BECOME LIVE WHEN THE EMBARGO LIFTS):

http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001281

PRESS-ONLY PREVIEW OF THE ARTICLE:

http://www.plos.org/media/press/2012/plme-09-08-kranzer.pdf

CONTACT:
Katharina Kranzer
London School of Hygiene and Tropical Medicine
London, United Kingdom
katharina.kranzer@lshtm.ac.uk